Episode 233 | Kevin Saem, Managing Director at Zapyrus | The Future of MedTech: Data-Driven Decisions & Investment Insights episode artwork

EPISODE · Sep 22, 2025 · 54 MIN

Episode 233 | Kevin Saem, Managing Director at Zapyrus | The Future of MedTech: Data-Driven Decisions & Investment Insights

from Project Medtech · host Project Medtech

In this episode, Duane Mancini welcomes back Kevin Saem, Managing Director of Zapyrus, for an enlightening discussion on the future of the MedTech industry. The episode delves into the latest trends in medtech funding, highlighting a significant increase in investments outside the U.S., the pivotal role of diagnostic technologies, and the importance of clinical data over revenue for attracting investments. Kevin shares groundbreaking advancements in data analytics and predictive machine learning applications, helping medtech companies and service providers enhance their commercialization strategies and efficiency. Kevin Saem LinkedInZapyrus WebsiteZapyrus H1/Q2 2025 MedTech Financial ReportDuane Mancini LinkedInProject Medtech WebsiteProject Medtech LinkedIn

Episode metadata supplied by the publisher feed · Published Sep 22, 2025

Embed this episode

NOW PLAYING

Episode 233 | Kevin Saem, Managing Director at Zapyrus | The Future of MedTech: Data-Driven Decisions & Investment Insights

0:00 54:32

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Project Medtech?

This episode is 54 minutes long.

When was this Project Medtech episode published?

This episode was published on September 22, 2025.

Can I download this Project Medtech episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!